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Summary
Objective: To address possible roles of matrix metalloproteinases (MMPs) and mechanical stress in the pathogenesis of osteochondrosis
(OC).
Methods: Naturally-occurring canine OC lesions (nZ 50) were immunohistochemically analyzed for MMP-1, -3, and -13, and normal canine
articular cartilage explants (nZ 6) cultured under 0-, 2-, or 4-MPa compressive loads (0.1 Hz, 20 min every 8 h up to 12 days) were compared
to OC samples (nZ 4) biochemically and molecularly.
Results: MMP-1 and -3 immunoreactivities were readily detected in both OC samples and control tissues obtained from age-matched dogs
(nZ 11) whereas MMP-13 was only detectable in OC samples. MMP-13 gene expression as determined by real-time reverse transcription
polymerase chain reaction was elevated in OC samples and cartilage explants cultured without mechanical stimuli (0 MPa groups) compared
to normal cartilage (day 0 controls). Glycosaminoglycan content (per weight) in cartilage explants cultured under no load was signiﬁcantly
(P! 0.05) lower on day 12 than in the day 0 controls. Gene expression levels of aggrecan and type II collagen in OC samples were lower than
those in the day 0 controls. High levels of aggrecan and collagen II expression were seen in the 2 MPa groups.
Conclusions: These ﬁndings imply that impaired biochemical characteristics in OC-affected cartilage may be attributable to decreased
extracellular matrix production that may stem from disruption of normal weight bearing forces.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
Osteochondrosis (OC) is a developmental orthopedic
disease commonly diagnosed across species1. Although
many factors including genetics, nutrition, hormonal dis-
turbances, trauma and ischemia are thought to play roles in
OC development, the disease mechanisms are not fully
understood. Since the pathophysiology of the disease has
high similarities between humans and animals1, studies of
OC using the dog as a model may deepen our insights into
the disease and contribute to elucidating its pathogenesis in
both humans and animals.
Tomlinson et al.2 reported that glycosaminoglycan (GAG)
content and immunoreactivity of collagen types I, II, and X
were different between cartilage affected by OC and normal
cartilage in dogs. Alterations in the biochemical character-
istics of cartilage extracellular matrix in OC lesions have
also been reported in other species3e5. Findings of these
studies suggest that disruption of the integrity of cartilage
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2004.extracellular matrix may play a role in the disease de-
velopment. The question remains whether abnormalities in
the extracellular matrix of cartilage affected by OC are the
result of decreased production of integral matrix molecules,
increased loss of these molecules, or both. A recent study
from our laboratory6 showed that cellular viability and matrix
composition in three-dimensional chondrocyte cultures from
OC lesions were inferior to those from normal cartilage. The
study indicated that at least a portion of matrix alterations in
cartilage affected by OC can be attributed to disruption of
matrix turnover by chondrocytes6. However, whether these
changes represent a cause or an effect of the disease is still
unknown. In addition to impaired production of matrix
macromolecules by chondrocytes, abnormal remodeling
and degradation of extracellular matrix may also contribute
to alterations in the biochemical characteristics of cartilage
affected by OC.
Matrix metalloproteinases (MMP) are known to play
important roles in articular cartilage extracellular matrix
turnover. In diarthrodial joints, MMP-1 (interstitial collage-
nases), MMP-3 (stromelysin-1), andMMP-13 (collagenase-3)
have been given great attention because of their known ability
to degrade cartilage-speciﬁc proteoglycans and collagens.
However, little information as to the expression of these
MMPs in naturally-occurring OC lesions is present in
the literature. Inappropriately high MMP levels would impli-
cate increased protease activity as a cause of abnormal
extracellular matrix in cartilage affected by OC, whereas225
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matrix abnormalities result from retarded matrix turnover.
Douglas and Rang7 have reported that traumatic me-
chanical stress on joints plays an important role in the
pathogenesis of OC. Since biomechanical forces have
been incriminated as a possible etiologic factor in OC,
further investigation involving precisely controlled mechan-
ical forces on articular cartilage may help to delineate the
roles of mechanical force in disease development. Re-
cently, a computer-driven dynamic pressure transmitter
system has been used to investigate the effects of
mechanical forces on cultured cells and tissues making
this type of investigation possible8e11. Therefore, the
objectives of the present study were to determine immuno-
reactivity of MMP-1, -3, and -13 in naturally-occurring OC of
dogs and to delineate the effects of compressive forces on
cellular and extracellular matrix characteristics of canine
cartilage explants. The hypotheses of the present study
were that altered expression of MMP-1, -3, and -13 would
be detected in naturally-occurring OC lesions of dogs and
that repetitive high compressive loads on normal canine
articular cartilage explants in vitro would alter character-
istics of chondrocytes and extracellular matrix similar to
those of naturally-occurring canine OC.
Materials and methods
SAMPLE COLLECTION
For the MMP immunohistochemical study, detached
articular cartilage ﬂaps (nZ 50) from OC lesions of the
humeral head were collected from 39 client-owned dogs
(range 4e30 months of age, mean 10.4 months) either
arthroscopically or after arthrotomy. Grossly normal, full-
thickness articular cartilage samples (nZ 11) were ob-
tained from the caudocentral humeral head of 11 young
adult dogs (range 7e18 months of age, mean 15.4 months)
immediately after euthanasia performed for reasons un-
related to this study. Cartilage samples were placed in 10%
buffered formalin for routine histologic processing and 5-
micron sections were obtained.
For the in vitro mechanical loading study, full-thickness
articular cartilage slices were aseptically obtained from the
caudocentral portion of the humeral head of six young adult
canine cadavers (range 12e24 months of age) via
arthrotomy performed immediately after euthanasia. The
dogs were euthanatized for reasons unrelated to this study
and were apparently healthy with grossly normal humeral
head cartilage. Using a 4-mm dermal punch, uniform-sized
full-thickness cartilage explants were obtained from each
dog. Cartilage samples collected immediately after eutha-
nasia served as day 0 controls for analyses of histology,
biochemistry, and gene expression. Remaining cartilage
explants from each dog were placed in 6-well BioFlex
plates (Flexcell International, Hillsborough, NC) with one
explant per well. Cartilage explants from each dog were
prepared in triplicate for histology, biochemistry, and gene
expression analyses and were bathed with 3 ml of
Dulbecco’s modiﬁed eagle medium supplemented with
10% fetal bovine serum, antibiotics (100 IU/ml penicillin,
100 mg/ml streptomycin, 2.5 mg/ml amphotericin B), and
ascorbate (50 mg/ml). A FX-4000C Flexercell Compres-
sion Plus Unit (Flexcell International) was used to apply
cyclic compressive loads on cartilage explants. Cyclic
compression was driven by air pressure, which was
monitored with an in-line manometer and controlled by
solenoid valves using FlexSoft software (FlexcellInternational). Load was applied at a frequency of 0.1 Hz
at 5.6 lb or 11.2 lb for 20 min, every 8 h through the BioFlex
plate piston (Flexcell International). Substantial loads
applied on cartilage explants were calculated based on
the formula; pressureZ force/area. With a 4 mm diameter
explant in each well, the pressures applied in the present
study: 5.6 lb and 11.2 lb correspond to loads of 2 MPa and
4 MPa applied onto the cartilage, respectively. Cartilage
explants cultured in the identical environment with no
compressive load applied served as 0 MPa groups. The
explants were incubated at 37(C with 5% CO2 and 95%
humidity. The explants were collected on days 6 and 12 and
the media were collected and refreshed every 3 days for
evaluation of the effects of compressive loading.
MMP IMMUNOHISTOCHEMISTRY
Immunohistochemistry was performed on ex vivo carti-
lage samples (naturally-occurring OC and normal carti-
lages) as well as cartilage explants undergoing mechanical
loading using mouse monoclonal antibodies against human
MMP-1, -3, and -13 (Oncogene Research Products, Cam-
bridge, MA) as previously described12. The immunostained
sections were subjectively evaluated for the presence and
location of staining and scored by two investigators who
were blinded to sample group on the basis of the presence
(1) or the absence (0) of positive staining.
CELL VIABILITY
Chondrocyte viability in cartilage explants was deter-
mined with use of ethidium homodimer-1 (13 ml/ml) and
calcein AM (0.4 ml/ml) ﬂuorescent stains (Live/Dead Viabil-
ity/Cytotoxicity Kit, Molecular Probes, Eugene, OR) and
a confocal laser microscopy (BioRad Radiance 2000
confocal system coupled to an Olympus IX70 inverted
microscope) equipped with KryptoneArgon mixed lasers
and a red diode laser. Approximately 1.5 mm thickness
cartilage cross-sections were incubated with the stains in
phosphate buffered saline for 30 min at room temperature.
The number of calcein AM stained live cells (green
ﬂuorescence) and ethidium homodimer-1 stained dead
cells (red ﬂuorescence) of all explants were objectively
evaluated using image analysis software (Image-Pro Plus,
MediaCybernetics, Carlsbad, CA).
EXTRACELLULAR MATRIX EVALUATION
To evaluate proteoglycan distribution within the tissue
matrix, samples were processed using routine histological
procedures and 5 mm sections were stained with toluidine
blue (T-blue). In addition, GAG in cartilage explants and in
liquid media were quantitated by DMMB assay13. Brieﬂy,
collected cartilage explant samples were lyophilized (Free-
Zone, Labconco, Kansas City, MO), weighted (dry weight),
and digested in 1 ml of 0.5 mg/ml papain (Sigma, St. Louis,
MO) in 20 mM sodium phosphate buffer (pH 6.8) containing
1 mM EDTA at 60(C overnight. A 5 ml aliquot of the digest
solution was assayed for total GAG content (GAG/dry
weight) by addition of 245 ml of DMMB solution and
spectrophotometric determination of absorbance at
525 nm with known concentrations of chondroitin sulfate
as standards. Results were standardized to correct for
differences in sample weight. Total GAG content for
samples was reported in micrograms per milligram. GAG
content in liquid medium samples (5 ml) were assayed by
227Osteoarthritis and Cartilage Vol. 13, No. 3addition of 245 ml of DMMB solution and spectrophotometric
determination of absorbance at 525 nm. GAG loss from the
explant was determined by calculating GAG content in the
liquid media as a percentage of total GAG in the explant for
each sample.
For collagen matrix evaluation, total collagen contents of
the cartilage explants were determined by measuring
hydroxyproline (HP) using a colorimetric procedure14 as
previously described15. Presence and distribution of type I,
II, and X collagens in cartilage explants were subjectively
determined with use of an avidinebiotin immunohistochem-
ical technique as previously described2.
REAL-TIME REVERSE TRANSCRIPTION POLYMERASE
CHAIN REACTION (REAL-TIME RT-PCR)
Total RNA was extracted from naturally-occurring OC
lesions of the humeral head collected from four client-
owned dogs (nZ 4, range 6e7 months of age, mean 6.4
months) and the cartilage explants from the in vitro
mechanical loading study and analyzed by RT-PCR using
primers (Table I) corresponding to cDNA sequences for
structural matrix macromolecules (type I and II collagens,
aggrecan, and decorin), proteinases (MMP-3 and MMP-13),
proteinase inhibitors (TIMP-1, TIMP-2, and TIMP-3), and
the house keeping gene glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH).
Snap frozen cartilage samples were powdered, trans-
ferred to a 0.5 ml screw cap tube ﬁlled with 1.0 mm diameter
Zirconia Beads (BioSpec Products, Bartlesville, OK) and
Trizol reagent (Invitrogen, Carlsbad, CA), and homoge-
nized using a mini-bead beater (BioSpec Products) at
5000 rpm for 2 min. RNA was extracted from the homoge-
nates using the TRIspin method as described16. RNA was
converted to cDNA using random hexamer primers and the
StrataScript RT enzyme (StrataGene, La Jolla, CA). Real-
Time PCR was performed with the Rotor-Gene RG-3000
(Corbett Research, Sydney, Australia) using the Quantitect
SYBR green PCR kit (Qiagen, Valencia, CA) following the
manufacturers guidelines. Primer sets were designed for
each gene, and tested using this system to ensure thateach set produced a single product. The PCR products
were then sequenced and compared to known sequences
using BLAST17 to ensure the speciﬁcity of the primer sets.
The melt curve data obtained during this testing were then
utilized to determine the speciﬁcity of subsequent PCR
tests in this study. The PCR proﬁle for all tests consisted of
an initial incubation at 94(C for 15 min, followed by 55
cycles of 5 s at 94(C, 10 s at 57(C and 20 s at 72(C. After
the PCR proﬁle a melt curve analysis was done to ensure
speciﬁc ampliﬁcation for each sample. SYBR green
ﬂuorescence was monitored during the extension step of
the PCR proﬁle, and take-off values and ampliﬁcation
efﬁciencies were determined using the Rotor-Gene soft-
ware. Relative expression levels for the target genes
studied were determined using Q-Gene and expressed as
a ratio to the level of GAPDH expression18. Real-time PCR
analysis was performed at least twice for each cartilage
sample. Means (%) of S.E.M. of normalized expression of
samples between assays were smaller than 20%, indicating
the reproducibility of real-time PCR was high. The no-RT
controls were negative for each primer set utilized, in-
dicating genomic DNA contamination was undetectable.
STATISTICAL ANALYSIS
All statistical analyses were performed using a computer
software program (SigmaStat, Jandel Scientiﬁc, San
Rafael, CA). In the study of MMP immunohistochemistry
for OC lesions, the presence or absence of staining of each
MMP was compared using a ManneWhitney rank sum test.
Case correlation coefﬁcients among the different parame-
ters were determined by Spearman rank order correlation.
For the in vitro mechanical loading study, data from each
collection day in each group were combined and meansG
standards errors (S.E.M.) were determined. A one-way
ANOVA was performed to determine differences among
treatment groups with respect to each assay at each
collection time. When signiﬁcant differences among groups
were obtained, an all pair-wise multiple comparison (Tukey
test) was performed to determine which groups were
different from each other. Differences compared to dayTable I
Oligonucleotide primers used for RT-PCR (fw: forward primer; rv: reverse primer)
Target template PCR primers Ampliﬁcation
product size (bp)
Col 2 fw: 5#-TGGAGCAGCAAGAGCAAGGA-3# 563
rv: 5#-ATCAGGTCAGG TCAGCCATTC-3#
Co1 1 fw: 5#-ACCTGCCGCGACCTCAAGATG-3# 551
rv: 5#-CAACGTCCA AGGTGCCACA-3#
Aggrecan fw: 5#-ACT GTTTCCCAGGAACTTGC-3# 607
rv: 5#-TGG GTCTCCTCTCCTGAGT-3#
Decorin fw: 5#-ATCTCCGCTGTTGACAATGG-3# 290
rv: 5#-TGGCAGAGCGCACGTAGAC-3#
MMP-3 fw: 5#-ATGGCATCCAGTCCCTGTAT-3# 161
rv: 5#-AAAGAACAGGAACTCTCCCC-3#
MMP-13 fw: 5#-GCCTTCCTCTTCTT GAGCTG-3# 320
rv: 5#-TTGGACCACTTGAGAGTTCG-3#
TIMP-1 fw: 5#-GCCCAGAG AGACTCACCAGA-3# 472
rv: 5#-CTCAC AGCCAGCAGCATAGG-3#
TIMP-2 fw: 5#-GACCAGACAAGGACATAG AG-3# 488
rv: 5#-TCAGAGCTGGACCAGT CTAA-3#
TIMP-3 fw: 5#-AACTCCGACATCGTGATCCG-3# 347
rv: 5#-GTAGTAGCAGGACTTG ATCT-3#
GAPDH fw: 5#-CCACGGCAAATTCCAC GGCACAG-3# 652
rv: 5#-GGGGTCCCTCCGATGCCTG CTTC-3#
Primers correspond to cDNA sequences deposited in GeneBank. Col 2Z collagen II, Col 1Z collagen I.
228 K. Kuroki et al.: MMP and mechanical stress in OC0 controls with respect to each assay at different collection
times were analyzed in a similar manner. Signiﬁcance was
established at P! 0.05.
Results
MMP IMMUNOHISTOCHEMISTRY FOR
NATURALLY-OCCURRING OC
In normal cartilage controls (nZ 11), MMP-1 and -3 were
detected in eight samples. When detected, MMP-1 was
identiﬁed in chondrocytes in the middle and deep zones
[Fig. 1(A)], whereas MMP-3 was diffusively distributed in
interterritorial regions of each zone of the matrix, except for
zone of calciﬁcation [Fig. 1(B)]. A weak, positive correlation
(PZ 0.03, rZ 0.28) was found between the presence of
MMP-1 and -3 in controls. No MMP-13 staining was present
in control samples [Fig. 1(C)]. In OC samples (nZ 50), 22
specimens stained positive for MMP-1 and 20 specimenswere positive for MMP-3. When present, distribution of
MMP-1 [Fig. 1(D)] and MMP-3 [Fig. 1(E)] in OC samples
was similar to those in controls. MMP-13 was detected in 21
OC-affected cartilage samples [Fig. 1(F)]. There was
a statistically signiﬁcant difference between groups with
signiﬁcantly (P! 0.001) more cartilage affected by OC
staining positive for MMP-13 than controls.
CELL VIABILITY
The effects of in vitro compressive loading of cartilage
explants were evaluated with confocal laser microscopic
analysis for cell viability. The majority of chondrocytes in
cartilage explants in the 0 MPa and 2 MPa groups
[Fig. 2(A,B)] emitted green ﬂuorescence at each sample
collection time indicating the maintenance of cell viability
throughout the study period. In contrast, many chondro-
cytes in explants from the 4 MPa group emitted redFig. 1. Representative photomicrographs of MMP-1 (A, D), MMP-3 (B, E), and MMP-13 (C, F) immunostaining in controls (A, B, C) and in OC-
affected cartilages (D, E, F). MMP-1 was identiﬁed in the cytoplasm of chondrocytes in the middle and deep zones (A, D), whereas MMP-3
was diffusively distributed in interterritorial regions of each zone of the matrix, except for the calciﬁcation zone (B, E). Note the intensity of
immunostaining in OC-affected cartilages (D, E) was apparently stronger than those in controls (A, B). No MMP-13 staining was detectable
in control samples (C), while it was detectable in OC-affected cartilages (F). Avidinebiotineperoxidase stain; original magniﬁcationZ 20!.
229Osteoarthritis and Cartilage Vol. 13, No. 3Fig. 2. Photomicrographs of confocal laser microscopy of tissue cross-sections from articular cartilage explants cultured under 0 MPa (A), 2 MPa
(B), and 4 MPa (C) for 12 days. On each image, the top is the cartilage surface. The green dots are live chondrocytes’ ﬂuorescent signals emitted
by calcein AM, and the red dots are dead chondrocytes’ ﬂuorescent signals emitted by ethidium homodimer. Note increased number of red dots in
the superﬁcial zone in the 4 MPa (C). (E) and (F) correspond to green dots and red dots in (C), respectively. Original magniﬁcationZ 10!.ﬂuorescence indicating reduced cell viability [Fig. 2(C)].
Analysis of chondrocytes emitting green ﬂuorescence or red
ﬂuorescence in each sample [Fig. 2(D,E)] showed that cell
viability in the 4 MPa group was signiﬁcantly (P! 0.05)
lower than in the 2 MPa group on day 6 and the 0 MPa
group on day 12 [Fig. 3(A)]. To verify the ﬁndings of cell
viability evaluated by confocal laser microscopy, diphenyl-
amine assay19 was conducted to quantify total DNA content
in cartilage explants, as described previously15. Similar to
the results shown by confocal laser microscopy, DNA
content in the 4 MPa group was decreased during the study
period and the reduction on day 6 and day 12 was
signiﬁcant (P! 0.05) compared to day 0 controls [Fig. 3(B)].
These results demonstrated that cell viability could be
maintained well under regimens of 0 MPa and 2 MPa
compressive loads at 0.1 Hz for 20 min, every 8 h, while
the 4 MPa regimen led to signiﬁcant cell death in this model.
EXTRACELLULAR MATRIX EVALUATION
The effects of different compressive loads on cartilage
explant extracellular matrix macromolecules were evalu-
ated. Compared to the day 0 controls, GAG content was
signiﬁcantly (PZ 0.036) decreased in the 0 MPa group on
day 12 (Fig. 4). In addition, T-blue histochemical analysis
showed the presence of decreased stained areas in the
superﬁcial to middle layers in the 0 MPa group (Fig. 5).
These ﬁndings corresponded well with each other and
indicated that the lack of mechanical stimuli on cartilage
leads to depletion of proteoglycans. Moreover, aggrecan
gene expression was apparently higher in the day 0 controls
compared to OC samples and the gene expression was
better preserved in the 2 MPa group (Table II). Gene
expression of decorin between OC samples and the
controls was unchanged (Table II).
In contrast to GAG content, collagen content in the 0 MPa
group as determined by the HP assay was minimally
affected during the study period (Fig. 6). A signiﬁcantDay 0 
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Fig. 3. (A) Mean (GS.E.M.) percent of live chondrocytes in articular
cartilage explants as determined by confocal laser microscopy with
image analysis software. The number of live cells was signiﬁcantly
lower in the 4 MPa group than in the 2 MPa group on day 6 and
than in the 0 MPa group on day 12. Reduction of live cells in the
4 MPa group on day 6 was also signiﬁcant compared to the day
0 controls. (B) Mean (GS.E.M.) DNA content (DNA/dry weight) in
articular cartilage explants as determined by diphenylamine assay.
DNA content in the 4 MPa group was signiﬁcantly decreased on
day 6 and day 12 compared to the day 0 controls (*P! 0.05).
230 K. Kuroki et al.: MMP and mechanical stress in OC(P! 0.05) decrease in collagen content for the 4 MPa
group was found on day 6 compared to the 0 MPa group
and the day 0 controls. Immunohistochemical analyses for
type I, II, and X collagens were conducted to further
elucidate the effects of compressive loads on collagen
extracellular matrix. Type II collagen expression was
diffusively present throughout the tissue with more intense
immunostaining in surface layers in the day 0 controls
[Fig. 7(A)]. Although all cartilage samples were positive for
type II collagen [Fig. 7(BeD)], immunoreactivity was sub-
jectively less intense in all treated groups compared to the
day 0 controls. In addition, collagen II gene expression was
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Fig. 4. (A) Mean (GS.E.M.) GAG content in articular cartilage
explants (GAG/dry weight) as determined by dimethylmethylene
assay. GAG in the 0 MPa group was signiﬁcantly decreased on day
12 compared to the day 0 control (*PZ 0.036). (B) GAG loss from
the cartilage explant calculated as a mean (GS.E.M.) percentage of
total GAG. %-GAG loss was not varied among groups throughout
the study period.higher in the day 0 controls compared to OC samples and
collagen II gene expression was best preserved in the
2 MPa groups among the three treatment regimens
(Table II). Type X collagen immunohistochemistry showed
collagen X to be concentrated in the territorial and
interterritorial regions of chondrocytes in superﬁcial to
middle layers [Fig. 7(E)] and immunostaining was well
preserved in those samples cultured under compressive
loads [Fig. 7(FeH)]. No cartilage explants were positive for
type I collagen (data not shown) and collagen I gene
expression was signiﬁcantly (P! 0.05) higher in OC
samples than the day 0 controls. None of the treatment
regimens induced collagen I gene expression (Table II).
MMP EVALUATION
In order to investigate whether MMPs play a role in the
alterations noted in the matrix molecules of loaded cartilage
explants, immunohistochemistry for MMP-1, -3, and -13 and
real-time RT-PCR for MMP-3 and -13 were performed.
Similar to those data seen in the MMP immunohistochem-
istry on normal cartilage samples, some cartilage samples
in day 0 controls were positive for MMP-1 (5/6) and MMP-3
(2/6) and none of day 0 controls stained positive for MMP-
13 (0/6). When MMP staining was detected, staining
patterns were similar to those seen in the ﬁrst study
(Fig. 1) and the presence and distribution of each MMP
were not signiﬁcantly varied throughout the culture period
(data not shown). Interestingly gene expression of MMP-13
was apparently higher in OC samples compared to the day
0 controls and its expression was higher in the 0 MPa
groups than the day 0 controls with a signiﬁcant (P! 0.05)
difference on day 6 (Table II).
In contrast, MMP-3 gene expression in OC samples and
the day 0 controls was not signiﬁcantly different. The
signiﬁcantly (P! 0.05) lower levels of TIMP-2 and TIMP-3
gene expression in OC samples compared to the day
0 controls implies imbalance between MMP and TIMP in
cartilage affected by OC (Table II).
Discussion
Only a limited number of studies have looked into
potential roles for MMPs in the pathophysiology of OC.
Brama et al.20,21 reported that MMPs in OC-affected equine
synovial ﬂuid were not signiﬁcantly different from those in
synovial ﬂuid obtained from normal horses and proposed
that MMP-mediated extracellular matrix destruction is not of
major importance in OC. Similarly, a study of naturally-
occurring canine OC showed that concentrations of MMP-3
in synovial ﬂuid obtained from OC-affected joints were notFig. 5. Representative photomicrographs of cross-sections of articular cartilage explants harvested on day 0 (A) and cultured under 0 MPa (B),
2 MPa (C), and 4 MPa (D) for 12 days. Sections were stained with toluidine blue. Note the deﬁnite loss of the stain from the superﬁcial to the
middle zones in the 0 MPa (C). Original magniﬁcationZ 20!.
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.different from those in normal synovial ﬂuid22. However,
MMPs are produced by various cell types within multiple
joint tissues, and therefore, MMPs in the synovial ﬂuid may
not reﬂect all potential roles of MMPs in the pathogenesis of
OC. Clegg and Carter23 reported gelatinase (MMP-2 and
-9) production by OC-affected cartilages obtained from
horses. Similarly, a recent investigation of equine OC using
in situ gelatin zymography demonstrated increased gelat-
inase activity in OC-affected cartilages24. However, these
studies could not provide deﬁnitive evidence as to whether
the gelatinase production was a causative or resultant event
in OC. To the authors’ knowledge, there are no data in the
literature that conclude that increases in MMPs are directly
responsible for loss of cartilage matrix integrity in OC.
The results of MMP analyses in the present study
demonstrated that MMP-13 immunoreactivity was only
detectable in OC samples and MMP-13 gene expression
was higher in OC than normal cartilage tissues. Although
the expression of MMPs as determined by immunohisto-
chemistry and real-time RT-PCR may not accurately reﬂect
enzyme activity, the ﬁndings in the present study are not
contradictory to a recent study that showed increased
collagenase-generated COL2-3/4short in equine OC carti-
lage25. Although MMP-13 expression identiﬁed in OC-
affected cartilage samples may represent a cause or an
effect of OC, elevated gene expression of MMP-13 in those
explants cultured without dynamic compressive loads in the
present study implies that an increase in MMP-13 expres-
sion in OC samples might be related to a disruption of
normal weight bearing forces in OC-affected joints. A
decline in TIMP-2 and TIMP-3 synthesis in OC, as
suggested by gene expression data from the present study,
may magnify the imbalance between MMP and TIMP,
leading to further matrix degradation. Caution is necessary
with respect to interpretation of gene expression data in this
study based on the number of samples studied and the
inherent variability in gene expression seen among different
animals.
In humans, normal physiological stresses on hip joint
cartilage have been reported to be as high as 18 MPa26.
Although pressures in canine shoulder joints under phys-
iological stresses are not known, it can be speculated that
2 MPa falls within the range of physiological pressures,
while 4 MPa may approach supraphysiological pressures
based on the weight of these dogs (between 25 and 30 kg),
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Fig. 6. Mean (GS.E.M.) hydroxyproline (HP) content (HP/dry weight)
in articular cartilage explants. HP content was signiﬁcantly de-
creased in the 4 MPa group on day 6 compared to the 0 MPa group
and the day 0 control (*P! 0.05).
232 K. Kuroki et al.: MMP and mechanical stress in OCFig. 7. Representative photomicrographs of cross-sections of articular cartilage explants harvested on day 0 (A, E) and cultured under 0 MPa
(B, F), 2 MPa (C, G), and 4 MPa (D, H) for 12 days. Sections were stained with antibodies against type II collagen (AeD) or type X collagen
(EeH). Type II collagen (AeD) was detected in the territorial and interterritorial regions of cartilage matrix and its immunoreactivity was
subjectively less intense in all treatment groups (C, D, E), especially samples from the 4 MPa group compared to the day 0 controls (A).
Type X collagen (EeH) was detectable in the territorial and interterritorial regions in the superﬁcial to middle zones. Note type X collagen
immunoreactivity was better preserved in explants cultured under compressive forces (G, H). Avidinebiotineperoxidase stain; original
magniﬁcationZ 20!.distribution of weight bearing to the forelimbs in dogs, and
data from the human literature26. The present in vitro study
clearly demonstrated that compressive loading of 4 MPa on
canine articular cartilage explants with a frequency of
0.1 Hz for 20 min every 8 h causes increased cell death,
especially in more superﬁcial zones. Although cartilage
necrosis is a common pathological feature associated with
OC in dogs2, the area of necrosis is usually a focal area
within the intermediate and deep zones of developing
articular or epiphyseal cartilage. Therefore, the mechanism
causing cell death associated with high compressive
loading is likely different from that seen in naturally-
occurring OC.
Destruction of proteoglycan matrix as determined by
GAG loss to the media was not signiﬁcantly different among
groups throughout the study period and this ﬁnding was
consistent with a recent study in which no evidence of
increased proteoglycan degradation was observed in
equine OC24. In addition, the apparent decrease in
aggrecan gene expression levels in OC samples compared
to controls was in accordance with previous studies2e4
reporting decreased proteoglycan content in OC-affected
cartilage. Preservation of GAG content despite increased
cell death in explants in the 4 MPa group and decreased
GAG content despite well preserved cell viability in the
0 MPa group may be explained by differential effects of
compressive load on chondrocytes based on phenotype
and location as previously reported8,9. In fact, GAG levels in
the 4 MPa group normalized by DNA content were the
highest among the three treatment groups followed by the
2 MPa group (data not shown). These data suggest that
physical destruction of cells and matrix in the superﬁcial
zone of loaded explants in this in vitro system with
concurrent stimulus to the middle and deep zones
appropriate for proteoglycan synthesis may occur. It then
follows that disruption of proteoglycan matrix integrity in
OC-affected cartilage reported in previous studies2e4 maybe attributable to a lack of normal weight bearing stimuli
secondary to OC. Further evidence for incriminating a lack
of normal weight bearing stimuli as a cause for diminutive
proteoglycan content in OC-affected cartilage is present in
the proteoglycan depletion in articular cartilage seen with
prolonged unloading of a joint27,28.
Decreased collagen content in cartilage explants under
4 MPa dynamic compressive loads and maintenance of
collagen content in the 0 MPa group throughout the study
period despite increased MMP-13 gene expression levels
indicates that this alteration more likely stems from
mechanical destruction rather than enzymatic degradation.
The differential effects on collagen content and proteogly-
can content in this study may be explained by the structure
of articular cartilage in which dense collagen ﬁbers are
distributed in the superﬁcial layer, which has a relatively low
amount of proteoglycan. It can be speculated that the
compressive loading associated with direct contact of
cartilage and the bioreactor in this system had a negative
impact on the collagen-dense superﬁcial zone, resulting in
prominent reduction of collagen content. The result of
collagen II gene expression is suggestive of the importance
of mechanical stimuli for transcriptional regulation of type II
collagen expression, and further, both lack of load and
excess load may cause alterations in the biochemical
characteristics of cartilage extracellular matrix.
Increased type I collagen gene expression in OC
samples veriﬁed our previous study2 in which 28 of 42
OC-affected canine cartilage samples were positive for
collagen type I while normal cartilage had no detectable
type I collagen as determined by immunohistochemistry.
Although the present study indicated that compressive
loads alone do not affect this shift in collagen synthesis,
future research is needed to determine whether type I
collagen expression is a cause or an effect of the disease.
Type X collagen immunoreactivity was well preserved for
cartilage explants cultured under compressive loads in the
233Osteoarthritis and Cartilage Vol. 13, No. 3present study. Although type X collagen has been
considered as a speciﬁc product of hypertrophic chondro-
cytes at sites of endochondral ossiﬁcation, it has also been
identiﬁed in the surface of normal articular cartilage in
various species including adult dogs29,30. The observation
of type X collagen in superﬁcial to middle zones and the
persistence of its expression in cartilage explants cultured
under compressive loads in this study may support previous
studies that indicated that type X collagen could contribute
to the structural integrity of articular cartilage31 and that
expression of this collagen might be regulated by mechan-
ical forces32,33. A previous study2 showed that OC-affected
cartilage in dogs had signiﬁcantly less type X collagen than
did normal cartilage. Further investigation including gene
expression analysis is necessary to elucidate whether the
decrease in type X collagen is relevant to the disturbance of
endochondral ossiﬁcation or due to the disruption of normal
weight bearing secondary to OC.
The unknown duration of the disease at the time of
surgical intervention is always a major issue in the
investigation of OC using naturally-occurring samples.
The median age for the onset of lameness associated with
humeral head OC in canines has been reported to range
between 5 and 6 months34. The initiation of the disease
process would occur even earlier than notable lameness.
The time lag from the onset of disease, to the diagnosis,
and subsequent surgical intervention may conceal critical
pathologic alterations in OC cartilage samples. OC is a very
common cause of secondary OA in dogs. In addition,
disruption of the normal weight bearing forces on OC-
affected articular cartilage is likely to cause tissue atrophy.
Future investigation using OC cartilage samples should
attempt to adapt a rigorous scientiﬁc method to select
samples which represent the early stages of the disease
processes.
Although in vitro compressive loading did not alter the
gene expression proﬁles in cartilage explants similar to
those in OC samples, our ﬁndings suggested that the
extracellular matrix composition and integrity altered by OC
and loads appears to be related to viability and synthetic
capabilities of chondrocytes, perturbations of cell pheno-
type, and alterations and imbalances in MMP and TIMP
synthesis. Further deﬁning the in vivo processes of disease
and reﬁnement of this model may allow for attainment of
a representative in vitro model for the study of OC.
Development of an OC model would then allow for directed
research into the mechanisms of disease and provide
avenues for optimal prevention and treatment across
species.
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